UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 11, 2011
ANAVEX LIFE SCIENCES
CORP.
(Exact name of registrant as specified in its
charter)
Nevada | 000-51652 | 20-8365999 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
50 Harrison Street, Suite 315A, Hoboken, New Jersey
07030
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code 1-800-689-3939
N/A
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e -4(c))
2
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
The information provided under this Item 5.02 is responsive to the information required by Item 5.07 and is hereby incorporated by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders
On April 11, 2011 we held our annual meeting of stockholders.
Election of Directors
At the annual meeting, our stockholders elected Cameron Durrant, Harvey Lalach, Sean Lowry and Alison Ayers as directors of our company with the following votes:
For | Against | Abstain | |
Cameron Durrant | 7,867,422 | 2,364,789 | 6,263 |
Harvey Lalach | 10,208,361 | 24,283 | 5,860 |
Sean Lowry | 10,218,620 | 13,591 | 6,293 |
Alison Ayers | 7,876,123 | 1,774,370 | 588,011 |
Appointment of Auditor
At the annual meeting, our stockholders ratified the appointment of BDO Canada LLP with the following votes:
For | Against | Abstain |
13,060,433 | 13,599 | 9,578 |
Stock Option Plan
At the annual meeting, our stockholders approved the increase in the number of shares of common stock issuable under the 2007 stock option plan with the following votes:
For | Against | Abstain |
10,068,615 | 152,257 | 17,632 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ANAVEX LIFE SCIENCES CORP.
/s/ Harvey Lalach
Harvey Lalach
President,
Chief Operating Officer and Director
Date: April 15, 2011